Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
Nutr Res ; 61: 64-81, 2019 01.
Artículo en Inglés | MEDLINE | ID: mdl-30683440

RESUMEN

Flavonoid consumption has reported health benefits such as reducing cardiovascular disease risk factors, improving endothelial function, and delaying age-related cognitive decline. However, there are little dietary intake data for Australians, which limit our ability to make dietary recommendations to increase intakes to a level where health benefits are seen. The aim of this cross-sectional study was to determine the intake of flavonoids, flavonoid classes, and flavonoid subclasses of 1183 Australians aged 39 to 65 years using a validated 215-item food frequency questionnaire. Based on limited global flavonoid intake data, flavanols are the major dietary flavonoid and are found predominantly in tea and cocoa. As Australians are large tea drinkers, we anticipated that flavanols would be the major flavonoid in the Australian diet. The flavonoid content of foods was determined using a combination of the United States Department of Agriculture Databases and the Phenol-Explorer Database. One-way analysis of variance was undertaken to examine differences between flavonoid intake between men and women. Total flavonoid intake was 626 ±â€¯579 mg/d. Men and women consumed 566 ±â€¯559 mg and 660 ±â€¯588 mg of total flavonoids per day, respectively. Thearubigin accounted for 58% of the flavonoid intake. Women consumed more total flavonoids, thearubigins (both P < .01), anthocyanidins (P < .0001), flavan-3-ols, flavones, and flavonols (all P < .05) than men, whereas men consumed more flavanones than women (P = .01). There was no difference between sexes for the consumption of isoflavones. The data indicated that flavan-3-ols, predominantly thearubigin from tea, were the main flavonoid consumed by Australians. This information contributes to population flavonoid intakes, which should be considered when exploring flavonoid and health relationships.


Asunto(s)
Cacao/química , Camellia sinensis/química , Chocolate , Dieta , Conducta Alimentaria , Flavonoides/administración & dosificación , , Adulto , Anciano , Anciano de 80 o más Años , Antocianinas/administración & dosificación , Australia , Bebidas/análisis , Catequina/administración & dosificación , Catequina/análogos & derivados , Estudios Transversales , Bases de Datos Factuales , Femenino , Flavonoles/administración & dosificación , Humanos , Masculino , Persona de Mediana Edad , Encuestas Nutricionales , Extractos Vegetales/administración & dosificación , Polifenoles/administración & dosificación , Factores Sexuales
2.
Nutr Neurosci ; 18(2): 76-86, 2015 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24621069

RESUMEN

OBJECTIVE: Certain plant polysaccharides may provide psychological health benefits. The aim of this study was to evaluate whether they can acutely improve mood and cognitive function. METHOD: In a randomized, double-blind, placebo-controlled, between subjects design trial, 73 middle-aged adults consumed 4 g of a proprietary mixture of non-starch polysaccharides (NSPs) (Ambrotose® complex), a rice flour placebo, or a sucrose control. Participants completed testing at baseline and 30 minutes post-consumption. Acute effects of consumption on mood, cognition, and blood glucose were evaluated during mental tests designed to induce mental fatigue. RESULTS: Significant improvement in recognition and working memory performance was observed in the group that consumed NSP compared with placebo or sucrose. Improvements in memory performance following NSP intake were independent of changes in blood glucose. DISCUSSION: This is the first report of acute behavioural improvement following plant polysaccharide intake in healthy middle-aged adults under conditions of mental fatigue. The findings suggest that certain NSP may enhance memory performance through mechanisms other than elevated blood glucose.


Asunto(s)
Envejecimiento , Disfunción Cognitiva/prevención & control , Suplementos Dietéticos , Nootrópicos/uso terapéutico , Polisacáridos/uso terapéutico , Estudios de Cohortes , Método Doble Ciego , Femenino , Galactanos/uso terapéutico , Galactosa/análogos & derivados , Glucosamina/uso terapéutico , Humanos , Masculino , Mananos/uso terapéutico , Memoria a Corto Plazo , Fatiga Mental/prevención & control , Persona de Mediana Edad , Sustancias para Mejorar el Rendimiento/uso terapéutico , Reconocimiento en Psicología
3.
Appetite ; 82: 124-30, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-25042089

RESUMEN

Snack foods can contribute a high proportion of energy intake to the diet. Peanuts are a snack food rich in unsaturated fatty acids, protein and fibre which have demonstrated satiety effects and may reduce total energy intake, despite their high energy density. This study examined the effects of consuming Hi-oleic (oleic acid ~75% of total fatty acids) peanuts and regular peanuts (oleic acid ~50% and higher in polyunsaturated fatty acids) compared with a high carbohydrate snack (potato crisps) on satiety and subsequent energy intake. Using a triple crossover study design, 24 participants (61 ± 1 years) consumed iso-energetic amounts (56-84 g) of Hi-oleic or regular peanuts or (60-90 g) potato crisps after an overnight fast. Hunger and satiety were assessed at baseline, 30, 60, 120 and 180 minutes following snack consumption using visual analogue scales, after which a cold buffet meal was freely consumed and energy intake measured. The same snack was consumed on 3 subsequent days with energy intake assessed from dietary records. This protocol was repeated weekly with each snack food. Total energy intake was lower following consumption of Hi-oleic and regular peanuts compared with crisps, both acutely during the buffet meal (-21%; p<.001 and -17%; p< .01) and over the 4 days (-11%; p< .001 and -9%; p< .01). Despite these reductions in energy intake, no differences in perceived satiety were observed. The findings suggest peanuts may be a preferred snack food to include in the diet for maintaining a healthy weight.


Asunto(s)
Arachis/química , Ingestión de Energía , Conducta Alimentaria , Ácidos Oléicos/administración & dosificación , Solanum tuberosum/química , Anciano , Índice de Masa Corporal , Estudios Cruzados , Grasas de la Dieta/administración & dosificación , Fibras de la Dieta/administración & dosificación , Proteínas en la Dieta/administración & dosificación , Método Doble Ciego , Ácidos Grasos/administración & dosificación , Ácidos Grasos Monoinsaturados/administración & dosificación , Ácidos Grasos Insaturados/administración & dosificación , Femenino , Manipulación de Alimentos , Voluntarios Sanos , Humanos , Masculino , Persona de Mediana Edad , Saciedad , Bocadillos , Encuestas y Cuestionarios
4.
Nutrients ; 6(3): 974-84, 2014 Mar 03.
Artículo en Inglés | MEDLINE | ID: mdl-24594505

RESUMEN

Cross-sectional studies have reported positive relationships between serum lutein concentrations and higher physical activity levels. The purpose of the study was to determine whether increasing plasma lutein levels increases physical activity. Forty-four older adults (BMI, 25.3 ± 2.6 kg/m²; age, 68.8 ± 6.4 year) not meeting Australian physical activity guidelines (150 min/week of moderate to vigorous activity) were randomized to consume capsules containing 21 mg of lutein or placebo with 250 mL of full-cream milk per day for 4 weeks and encouraged to increase physical activity. Physical activity was assessed by self-report, pedometry and accelerometry (daily activity counts and sedentary time). Exercise self-efficacy was assessed by questionnaire. Thirty-nine participants competed the study (Lutein = 19, Placebo = 20). Lutein increased plasma lutein concentrations compared with placebo (p < 0.001). Absolute and percentage changes in plasma lutein were inversely associated with absolute (r = -0.36, p = 0.03) and percentage changes (r = -0.39, p = 0.02) in sedentary time. Percentage change in plasma lutein was positively associated with the percentage change in average daily activity counts (r = 0.36, p = 0.03). Exercise self-efficacy did not change (p = 0.16). Lutein increased plasma lutein, which was associated with increased physical activity and reduced sedentary time in older adults. Larger trials should evaluate whether Lutein can provide health benefits over the longer term.


Asunto(s)
Suplementos Dietéticos , Luteína/administración & dosificación , Luteína/sangre , Actividad Motora , Conducta Sedentaria , Acelerometría , Actividades Cotidianas , Anciano , Anciano de 80 o más Años , Índice de Masa Corporal , Colesterol/sangre , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Autoinforme , Xantófilas/administración & dosificación , Xantófilas/sangre , Zeaxantinas
5.
J Hypertens ; 31(9): 1819-27, 2013 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-23743811

RESUMEN

BACKGROUND: We have previously demonstrated acute dose-dependent increases of flow-mediated dilatation (FMD) in the brachial artery after resveratrol consumption in mildly hypertensive, overweight/obese adults. Resveratrol supplementation has also been shown to increase cerebral blood flow acutely, without affecting cognition. OBJECTIVES: To evaluate the effects of chronic resveratrol supplementation on both FMD and cognitive performance. METHOD: Twenty-eight obese but otherwise healthy adults (BMI: 33.3 ± 0.6 kg/m) were randomized to take a single 75 mg capsule of trans-resveratrol (Resvida) or placebo daily for 6 weeks each in a double-blind crossover supplementation trial. Blood pressure, arterial compliance, FMD, and performance on the Stroop Color-Word Test were assessed at the end of each 6-week intervention period while fasted and at least 18 h after taking the last daily capsule. An additional capsule of the same supplement was then taken. FMD assessment was repeated 1 h later. RESULTS: Chronic resveratrol supplementation for 6 weeks was well tolerated and resulted in a 23% increase in FMD compared with placebo (P=0.021, paired t-test). The extent of increase correlated negatively with baseline FMD (r=-0.47, P=0.01). A single dose of resveratrol (75 mg) following chronic resveratrol supplementation resulted in a 35% greater acute FMD response than the equivalent placebo supplementation. These FMD improvements remained significant after adjusting for baseline FMD. Blood pressure, arterial compliance, and all components of the Stroop Color-Word Test were unaffected by chronic resveratrol supplementation. CONCLUSION: Daily resveratrol consumption was well tolerated and has the potential to maintain healthy circulatory function in obese adults.


Asunto(s)
Arteria Braquial/efectos de los fármacos , Obesidad/fisiopatología , Estilbenos/uso terapéutico , Vasodilatación/efectos de los fármacos , Adulto , Anciano , Velocidad del Flujo Sanguíneo/efectos de los fármacos , Presión Sanguínea , Monitoreo Ambulatorio de la Presión Arterial , Índice de Masa Corporal , Arteria Braquial/patología , Arterias Carótidas/patología , Estudios Cruzados , Suplementos Dietéticos , Método Doble Ciego , Endotelio Vascular/fisiopatología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Sobrepeso , Posmenopausia , Resveratrol , Test de Stroop , Encuestas y Cuestionarios
6.
Nutr Rev ; 70(10): 594-610, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-23035806

RESUMEN

The purpose of this review is to outline the current evidence regarding the effects of micronutrient and omega-3 polyunsaturated fatty acid (n-3 PUFA) supplementation on the cognition, learning, and behavior of children and adolescents living in developed societies. Existing evidence suggests that children and adolescents in developed countries may perform better on tests of nonverbal intelligence and on behavioral measures after receiving vitamin and mineral supplements with or without n-3 PUFA supplementation compared with those receiving placebo, regardless of age and supplementation formula. The strongest effects were observed in trials that lasted over 3 months and in subgroups of children with low socioeconomic status, symptoms of attention deficit hyperactivity disorder, and/or learning disabilities. Future studies should focus on children and adolescents who have a low socioeconomic status or are likely to be suffering nutritional deficiencies to determine the impact of vitamin and mineral supplements with or without n-3 PUFA supplementation on their cognitive and behavioral functioning. These studies should ideally include blood sample analyses to help determine if nutritional status influences the response to supplementation and whether changes in blood status account for effects on cognition and behavior.


Asunto(s)
Conducta del Adolescente/efectos de los fármacos , Conducta Infantil/efectos de los fármacos , Suplementos Dietéticos , Ácidos Grasos Omega-3/administración & dosificación , Micronutrientes/administración & dosificación , Adolescente , Conducta del Adolescente/fisiología , Niño , Conducta Infantil/fisiología , Cognición/efectos de los fármacos , Cognición/fisiología , Países Desarrollados , Femenino , Humanos , Aprendizaje/efectos de los fármacos , Aprendizaje/fisiología , Masculino , Estado Nutricional
7.
Nutrients ; 4(5): 331-42, 2012 05.
Artículo en Inglés | MEDLINE | ID: mdl-22690320

RESUMEN

BACKGROUND AND AIM: Preliminary evaluation of a wild green oat extract (WGOE) (Neuravena(®) ELFA(®)955, Frutarom, Switzerland) revealed an acute cognitive benefit of supplementation. This study investigated whether regular daily WGOE supplementation would result in sustained cognitive improvements. METHOD: A 12-week randomised, double-blind, placebo-controlled cross-over trial of WGOE supplementation (1500 mg/day) versus placebo was undertaken in 37 healthy adults aged 67 ± 0.8 years (mean ± SEM). Cognitive assessments included the Stroop colour-word test, letter cancellation, the rule-shift task, a computerised multi-tasking test battery and the trail-making task. All assessments were conducted in Week 12 and repeated in Week 24 whilst subjects were fasted and at least 18 h after taking the last dose of supplement. RESULT: Chronic WGOE supplementation did not affect any measures of cognition. CONCLUSION: It appears that the cognitive benefit of acute WGOE supplementation does not persist with chronic treatment in older adults with normal cognition. It remains to be seen whether sustained effects of WGOE supplementation may be more evident in those with mild cognitive impairment.


Asunto(s)
Atención/efectos de los fármacos , Avena/química , Cognición/efectos de los fármacos , Suplementos Dietéticos , Extractos Vegetales/farmacología , Anciano , Estudios Cruzados , Método Doble Ciego , Femenino , Humanos , Masculino
8.
Appetite ; 58(1): 339-46, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22100487

RESUMEN

The aim of this research was to examine relationships between tea, coffee and other beverage consumption and associates of work performance and mood among individuals in relatively stressful and cognitively demanding work-place settings. Using a naturalistic, cross-sectional study design, 95 professional and academic staff logged their beverage intake and completed self-reports of associates of work performance (fatigue/exhaustion, mindfulness, work engagement), subjective work performance, mood, work-related strain and recovery four times daily during ten working days. Data were analysed using multilevel modelling in keeping with the hierarchical structure of the data. Tea consumption was associated with increased perceived work performance and reduced tiredness, especially when consumed without milk or sugar. Consumption of non-caffeinated beverages was associated with increased relaxation and recovery from work. In contrast, tea and other caffeinated beverages were found to enhance the negative effects of evening recovery and morning mood on mindfulness during the day. The findings suggest that beverage intake may have a role in optimising work-related psychological states and performance.


Asunto(s)
Afecto/efectos de los fármacos , Bebidas , Café/química , Té/química , Adulto , Animales , Australia , Cafeína/farmacología , Estudios Transversales , Fatiga/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad , Leche
9.
J Altern Complement Med ; 17(7): 635-7, 2011 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-21711204

RESUMEN

BACKGROUND AND AIMS: Extracts from oat (Avena sativa) herb may benefit cognitive performance. This study investigated whether Neuravena(®), an oat herb extract, could acutely improve responses to the Stroop Color-Word test, a measure of attention and concentration and the ability to maintain task focus. SUBJECTS AND METHODS: Elderly volunteers with below-average cognitive performance consumed single doses (0, 1600, and 2400 mg) of oat herb extract at weekly intervals in a double-blind, randomized, crossover comparison. Resting blood pressure (BP) was assessed before and after supplementation, and a Stroop test was performed. RESULTS: Significantly fewer errors were made during the color-naming component of the Stroop test after consuming the 1600-mg dose than after the 0-mg or 2400-mg doses (F (1,36)=18.85, p<0.001). In 7 subjects with suspected cognitive impairment, Stroop interference score was also improved by the 1600-mg dose compared to 0- and 2400-mg doses (F (1, 34)=2.40, p<0.01). Resting BP was unaffected by supplementation. CONCLUSIONS: Taking 1600 mg of oat herb extract may acutely improve attention and concentration and the ability to maintain task focus in older adults with differing levels of cognitive status.


Asunto(s)
Avena , Trastornos del Conocimiento/tratamiento farmacológico , Cognición/efectos de los fármacos , Fitoterapia , Extractos Vegetales/uso terapéutico , Anciano , Estudios Cruzados , Suplementos Dietéticos , Método Doble Ciego , Femenino , Humanos , Lenguaje , Masculino , Persona de Mediana Edad , Componentes Aéreos de las Plantas , Extractos Vegetales/farmacología , Test de Stroop
10.
Dev Neuropsychol ; 35(1): 66-80, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20390593

RESUMEN

The current study used a randomized, double-blind, placebo-controlled design to investigate the effects of saccharide supplementation on cognition and well-being in middle-aged adults. Participants (N = 109; 45-60 years) took a teaspoon of a combination of saccharides or a placebo twice daily for 12 weeks (3.6 g per day). Before and after this supplementation period, participants completed alternate forms of standardized tests of cognition and self-report measures of well-being. Significant beneficial effects of saccharide supplementation were found for memory performance and indicators of well-being. The potential for these nutrients to optimize cognitive function and well-being in older adults warrants ongoing investigation.


Asunto(s)
Carbohidratos/administración & dosificación , Cognición/efectos de los fármacos , Suplementos Dietéticos , Estado de Salud , Actividades Cotidianas , Análisis de Varianza , Atención/efectos de los fármacos , Método Doble Ciego , Femenino , Humanos , Masculino , Memoria/efectos de los fármacos , Persona de Mediana Edad , Pruebas Neuropsicológicas , Autoimagen , Encuestas y Cuestionarios , Factores de Tiempo
11.
Nutr Rev ; 66(2): 82-90, 2008 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-18254874

RESUMEN

This review summarizes the literature on the association between two dietary components of tea, caffeine and L-theanine, and the psychological outcomes of consumption; it also identifies areas for future research. The studies reviewed suggest that caffeinated tea, when ingested at regular intervals, may maintain alertness, focused attention, and accuracy and may modulate the more acute effects of higher doses of caffeine. These findings concur with the neurochemical effects of L-theanine on the brain. L-theanine may interact with caffeine to enhance performance in terms of attention switching and the ability to ignore distraction; this is likely to be reflective of higher-level cognitive activity and may be sensitive to the detrimental effects of overstimulation. Further research should investigate the interactive effects of caffeine, L-theanine, and task complexity, utilize a range of ecologically valid psychological outcomes, and assess the neuroprotective effects of L-theanine using epidemiological or longer-term intervention studies among individuals at risk of neurodegenerative disease.


Asunto(s)
Encéfalo/efectos de los fármacos , Cafeína , Glutamatos/fisiología , Té/química , Afecto/efectos de los fármacos , Atención/efectos de los fármacos , Bebidas , Encéfalo/fisiología , Cafeína/farmacología , Cognición/efectos de los fármacos , Humanos
12.
Am J Clin Nutr ; 86(4): 1082-93, 2007 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-17921387

RESUMEN

BACKGROUND: Little is known about the combined effect of micronutrients and essential fatty acids on cognitive function in school-aged children. OBJECTIVE: We assessed the effect of micronutrients, long-chain n-3 fatty acids, or both on indicators of cognitive performance in well-nourished and marginally nourished school-aged children. DESIGN: Two 2-by-2 factorial randomized controlled double-blind trials were performed home-based in Adelaide, South Australia, and at 6 primary schools in Jakarta, Indonesia. A total of 396 children (aged 6-10 y) in Australia and 384 children in Indonesia were randomly allocated to receive a drink with a micronutrient mix (iron, zinc, folate, and vitamins A, B-6, B-12, and C), with docosahexanoic acid (DHA, 88 mg/d) and eicosapentaenoic acid (EPA, 22 mg/d), or with both or placebo 6 d/wk for 12 mo. Biochemical indicators were determined at baseline and 12 mo. Cognitive performance was measured at baseline, 6 mo, and 12 mo. RESULTS: The micronutrient treatment significantly improved plasma micronutrient concentrations in Australian and Indonesian children. DHA+EPA treatment increased plasma DHA and total plasma n-3 fatty acids in both countries. The micronutrient treatment resulted in significant increases in scores on tests representing verbal learning and memory in Australia (estimated effect size: 0.23; 95% CI: 0.01, 0.46). A similar effect was observed among Indonesian girls (estimated effect size: 0.32; 95% CI: -0.01, 0.64). No effects were found on tests measuring general intelligence or attention. No effects of DHA+EPA on the factors of cognitive tests were observed. CONCLUSION: In well-nourished school-aged children, fortification with multiple micronutrients can result in improvements in verbal learning and memory.


Asunto(s)
Fenómenos Fisiológicos Nutricionales Infantiles , Ácidos Grasos Omega-3/administración & dosificación , Aprendizaje/efectos de los fármacos , Memoria/efectos de los fármacos , Micronutrientes/administración & dosificación , Estado Nutricional , Atención/efectos de los fármacos , Australia , Niño , Fenómenos Fisiológicos Nutricionales Infantiles/efectos de los fármacos , Fenómenos Fisiológicos Nutricionales Infantiles/fisiología , Método Doble Ciego , Ácidos Grasos Esenciales/administración & dosificación , Ácidos Grasos Esenciales/metabolismo , Ácidos Grasos Omega-3/metabolismo , Femenino , Alimentos Fortificados , Estado de Salud , Humanos , Indonesia , Inteligencia/efectos de los fármacos , Masculino , Recuerdo Mental/efectos de los fármacos , Micronutrientes/metabolismo , Resultado del Tratamiento
13.
J Dev Behav Pediatr ; 28(2): 82-91, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17435458

RESUMEN

METHODS: Various developmental problems including attention-deficit/hyperactivity disorder (ADHD) have been linked to biological deficiencies in polyunsaturated fatty acids (PUFAs). Additionally, there is evidence that symptoms may be reduced with PUFA supplementation. This study investigated effects of supplementation with PUFAs on symptoms typically associated with ADHD. Because nutrients work synergistically, additional effects of micronutrient supplementation were also investigated. A total of 132 Australian children aged 7 to 12 years with scores > or = 2 SD above the population average on the Conners ADHD Index participated in a randomized, placebo-controlled, double-blind intervention over 15 weeks, taking PUFAs alone, PUFAs + micronutrients, or placebo. Due to unreturned questionnaires, data were only available for 104 children. RESULTS: Significant medium to strong positive treatment effects were found on parent ratings of core ADHD symptoms, inattention, hyperactivity/impulsivity, on the Conners Parent Rating Scale (CPRS) in both PUFA treatment groups compared with the placebo group; no additional effects were found with the micronutrients. After a one-way crossover to active supplements in all groups for a further 15 weeks, these results were replicated in the placebo group, and the treatment groups continued to show significant improvements on CPRS core symptoms. No significant effects were found on Conners Teacher Rating Scales. CONCLUSION: These results add to preliminary findings that ADHD-related problems with inattention, hyperactivity, and impulsivity might respond to treatment with PUFAs and that improvements may continue with supplementation extending to 30 weeks.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/dietoterapia , Ácidos Grasos Insaturados/administración & dosificación , Micronutrientes/administración & dosificación , Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Trastorno por Déficit de Atención con Hiperactividad/psicología , Niño , Estudios Cruzados , Método Doble Ciego , Femenino , Estudios de Seguimiento , Humanos , Cuidados a Largo Plazo , Masculino , Australia del Sur
14.
Hum Psychopharmacol ; 21(1): 27-37, 2006 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-16329161

RESUMEN

Ginkgo biloba extracts are commonly used to prevent or treat memory problems but evidence on the efficacy of ginkgo is equivocal. In any case, the psychological locus of ginkgo's effects is unknown. A 12-week, double-blind, placebo-controlled study assessed effects of ginkgo (120 mg per day) on a wide range of cognitive abilities, executive function, attention and mood in 93 healthy older adults (55-79 years) and in 104 young adults (18-43 years). For the older adult sample, longer-term memory assessed by associational learning tasks showed improvement with ginkgo (d = 0.52, p = 0.04). There was no statistically significant difference on any other measure. For the young adult group no measure showed statistically significant effects of ginkgo enhancement. There were no side effects unequivocally attributable to treatment with ginkgo and those reported by participants in the ginkgo groups were mild and similar to those reported elsewhere.


Asunto(s)
Afecto/efectos de los fármacos , Cognición/efectos de los fármacos , Ginkgo biloba/química , Extractos Vegetales/farmacología , Adolescente , Adulto , Factores de Edad , Anciano , Análisis de Varianza , Aprendizaje por Asociación/efectos de los fármacos , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pruebas Neuropsicológicas/estadística & datos numéricos , Desempeño Psicomotor/efectos de los fármacos , Reproducibilidad de los Resultados
15.
Nutr Rev ; 61(12): 413-22, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14968911

RESUMEN

The accurate assessment of cognitive performance in children is critical for detecting the effects of micronutrient deficiency or supplementation on the developing brain and its functions. Relatively little attention has been paid to the selection of culturally appropriate measures that are sensitive enough to detect the subtle cognitive changes that could be expected following nutritional intervention. Normal brain development and the emergence of cognitive abilities throughout infancy and childhood is discussed in this paper, followed by a description of the more pertinent and sensitive neuropsychological tests that can be used to assess cognitive performance and investigate the effects of micronutrient deficiency and supplementation on cognitive development among children in a variety of cultures.


Asunto(s)
Cognición/fisiología , Desempeño Psicomotor/fisiología , Adolescente , Encéfalo/fisiología , Niño , Desarrollo Infantil/fisiología , Fenómenos Fisiológicos Nutricionales Infantiles/fisiología , Preescolar , Humanos , Lactante , Recién Nacido , Evaluación Nutricional
16.
J Nutr ; 132(6): 1345-56, 2002 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-12042457

RESUMEN

Based on research demonstrating associations between folate, B-12 and B-6 vitamins and cognition and mood, we investigated the effects of short-term supplementation in 211 healthy younger, middle-aged and older women who took either 750 microg of folate, 15 microg of vitamin B-12, 75 mg of vitamin B-6 or a placebo daily for 35 d. In addition, we examined associations between dietary intake of these vitamins and cognition and mood. Usual dietary intake status was estimated using a retrospective, self-report, quantified food frequency questionnaire. Participants completed alternate forms of standardized tests of cognitive processing resources, memory, executive function, verbal ability and self-report mood measures before and after supplementation. Supplementation had a significant positive effect on some measures of memory performance only, and no effect on mood. Dietary intake status was associated with speed of processing, recall and recognition and verbal ability.


Asunto(s)
Afecto/efectos de los fármacos , Envejecimiento/fisiología , Ácido Fólico/administración & dosificación , Memoria/efectos de los fármacos , Vitamina B 12/administración & dosificación , Vitamina B 6/administración & dosificación , Adulto , Afecto/fisiología , Anciano , Anciano de 80 o más Años , Envejecimiento/psicología , Dieta , Suplementos Dietéticos , Método Doble Ciego , Femenino , Ácido Fólico/fisiología , Humanos , Memoria/fisiología , Persona de Mediana Edad , Placebos , Vitamina B 12/fisiología , Vitamina B 6/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA